Trince Bio

Trince, a Belgian company based in Ghent, has developed the LumiPore platform, a revolutionary intracellular delivery technology facilitating the transport of functional compounds into cells. With a focus on genetic engineering, Trince targets immune cells for cancer therapy, stem cells like iPSCs, and live cell imaging. Their technology enables precise genetic modifications while preserving cell function and therapeutic potential. Using pulsed laser light and photothermal nanoparticles, Trince achieves localized forces to create temporary pores in cell membranes, termed "photoporation." This approach allows efficient, flexible, and safe delivery of molecules into various cell types.